Form 13-F position report

UNUM THERAPEUTICS INC

Reported by Atlas Venture Associates IX LLC

COGT CUSIP 19240Q201 Manager CIK 0001671207

Reported 916,832 shares, unchanged from the prior quarter.

Reported value -7.6%; share count 0.0% vs. the prior quarter.

Unchanged
% of reported 13F value 1.31% This manager · Q2 2021
Shares 916,832 Quarter-end amount reported
Reported value $7,436,000 Fair value at quarter end
Consecutive quarters held 3 Through Q2 2021

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value
2020-12-31 10289000
2021-03-31 8050000
2021-06-30 7436000
2021-09-30 7711000
2021-12-31 7866000
2022-03-31 6867000
2022-06-30 4211000
2022-09-30 0

Quarterly position history

How this manager's reported quarter-end position changed over time.

8 quarters
Quarterly reported position history for UNUM THERAPEUTICS INC held by Atlas Venture Associates IX LLC.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
Q3 2022 Reduced 0 -466,832 (-100.0%) 0 $0 2022-11-10
Q2 2022 Reduced 466,832 -450,000 (-49.1%) 9.57% $4,211,000 2022-08-11
Q1 2022 Unchanged 916,832 0 (0.0%) 6.32% $6,867,000 2022-05-12
Q4 2021 Unchanged 916,832 0 (0.0%) 3.43% $7,866,000 2022-01-27
Q3 2021 Unchanged 916,832 0 (0.0%) 2.56% $7,711,000 2021-11-04
Q2 2021 Unchanged 916,832 0 (0.0%) 1.31% $7,436,000 2021-08-11
Q1 2021 Added 916,832 +636 (0.1%) 1.35% $8,050,000 2021-05-14
Q4 2020 New 916,196 +916,196 (0.0%) 1.63% $10,289,000 2021-02-03

Who else reported the position

85 managers reported UNUM THERAPEUTICS INC for Q2 2021.

Managers reporting UNUM THERAPEUTICS INC in Q2 2021.
Manager Activity Shares Change % of reported 13F Reported value Tenure
PERCEPTIVE ADVISORS LLC Unchanged 3,188,750 0 0.34% $25,861,000 3 qtrs
BlackRock Inc Added 2,677,388 +2,109,352 < 0.01% $21,714,000 3 qtrs
JANUS HENDERSON GROUP PLC Added 2,438,201 +155,073 < 0.01% $19,785,000 3 qtrs
Candriam S C A Added 1,910,601 +1,435,900 0.11% $15,495,000 3 qtrs
Ally Bridge Group NY LLC Unchanged 1,622,591 0 3.27% $13,159,000 3 qtrs
VANGUARD GROUP INC Reduced 1,606,789 -527,454 < 0.01% $13,031,000 3 qtrs
DEERFIELD MANAGEMENT COMPANY L P SERIES C Added 1,601,000 +601,000 0.23% $12,984,000 3 qtrs
Ghost Tree Capital LLC Unchanged 1,600,000 0 3.57% $12,976,000 3 qtrs
Fairmount Funds Management LLC Unchanged 1,558,975 0 5.2% $12,643,000 3 qtrs
BVF INC IL Unchanged 1,532,282 0 0.47% $12,427,000 3 qtrs
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
June 30, 2021
Filed
August 11, 2021
Filing type
13F-HR
Position type
COM

Voting authority reported

Sole
916,832
Shared
0
None
0

“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.